Company news
Genedrive Plc (LSE:GDR) news
Genedrive Plc news releases on 6ix. Latest, Sep 26, 2022: NICE to accelerate evaluation of Genedrive test
Press releases — page 3
NICE to accelerate evaluation of Genedrive test
September 26, 2022
NICE includes CYP2C19-ID Kit in new programme
August 22, 2022
NICE to evaluate the Genedrive® MT-RNR1 Test
June 16, 2022
Point-of-Care COV19-ID Kit receives CTDA approval
May 30, 2022
NICE issues Medtech Innovation Briefing
March 29, 2022
PALOH study results published in JAMA Pediatrics
March 21, 2022
First NHS Deployments of Genedrive System for AIHL
March 18, 2022
Board appointment
March 17, 2022
Further re Directorate Change
March 2, 2022
Update on Point of Care Covid Test
February 23, 2022
UK CTDA application for Genedrive® COV19-ID kit
December 22, 2021
CE-IVD certification for Point-of-Care kit
December 8, 2021
Additional Listing of Shares
December 6, 2021
POC kit submitted for CE-IVD certification
November 29, 2021
Annual Report and Accounts and notice of AGM
November 17, 2021
Director's shareholding
October 11, 2021
Result of Open Offer
September 29, 2021
Result of Placing
September 10, 2021
New Genedrive system readied for AIHL launch
August 31, 2021
Genedrive COVID-19 Point of Care device update
July 1, 2021
Genedrive confirms receipt of India Import License
June 25, 2021
COVID-19 PCR test approved by Indian regulator
April 30, 2021
Excellent performance data for Genedrive® HCV test
April 23, 2021
PHE National Framework Agreement
April 19, 2021
Distribution agreement
March 9, 2021
Antibiotic Induced Hearing Loss update
March 3, 2021
Investor Presentation
March 1, 2021
First US shipments of Genedrive® 96 SARS-CoV-2 Kit
February 17, 2021
Distribution agreement with Beckman Coulter
January 28, 2021
Response to new COVID strain
December 21, 2020
Notification of intent to distribute in the USA
December 16, 2020
Conversion of Remaining Loan Notes
December 11, 2020
Additional Listing
December 7, 2020
AIHL hospital study completion
December 3, 2020
High clinical accuracy in India study
November 20, 2020
Point-of-Care solution to detect SARS-CoV-2 virus
October 22, 2020
South African approval
September 30, 2020
Partial Conversion of Loan Notes
September 28, 2020
Verification with Beckman Coulter Life Sciences
September 25, 2020
Collaboration to automate COVID-19 PCR testing
August 4, 2020
New Genedrive® 96 Exporter software
July 10, 2020
Conversion of Convertible Bond
June 16, 2020
Application for Block Listing
May 28, 2020
Genedrive : Result of General Meeting
May 27, 2020
Genedrive 96 SARS-CoV-2 Kit receives CE-IVD Mark
May 22, 2020
Results of Broker Option
May 12, 2020
Posting of shareholder circular
May 7, 2020
Proposed Placing and Broker Option
May 5, 2020
WHO Prequalification for Genedrive HCV-ID test
May 4, 2020
Manufacturing milestones met for SARS-CoV-2 test
May 1, 2020